DiviDrip · DNA

DNA — Ginkgo Bioworks Holdings, Inc.

DNA is Ginkgo Bioworks Holdings, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $6.95. Market cap: $473M. Capital Quality Rank: 19/100 — Capital destroyer.

Stock snapshot

Price$6.95
Market cap$473M
SectorHealthcare
ExchangeNYQ
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)19 / 100 · Capital destroyer
ROIC (TTM)-73.0%
Revenue CAGR (3y)-29.1%
Shareholder buyback yield-6.42%
Altman Z-score zoneDistress

About DNA

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Listed2021Employees485HQBoston, MASectorHealthcareWebsiteginkgobioworks.com

Related non-dividend companies

Other non-dividend stocks investors research alongside DNA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is DNA's current stock price?

DNA (Ginkgo Bioworks Holdings, Inc.) is currently trading at $6.95.

Does DNA pay a dividend?

DNA (Ginkgo Bioworks Holdings, Inc.) does not currently pay a regular dividend.

What is DNA's Capital Quality Rank?

DNA has a Capital Quality Rank of 19/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track DNA in DiviDrip

Add DNA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow